Khondrion is a Dutch biotechnology company developing innovative therapies for mitochondrial disorders. 3M Invest is involved as a strategic participant.
Khondrion focuses on developing treatment options for patients with rare and complex mitochondrial diseases. Few effective therapies exist for these conditions, which makes the medical need structural and international in nature.
The company combines scientific expertise with clinical development. Its intellectual property, research pipeline and clinical pathway together form the core of the proposition.
Khondrion operates in a sector where patience, governance and a long-term perspective determine value creation. That aligns directly with the three to seven year horizon 3M Invest applies.
Our role is that of strategic participant: capital combined with involvement in decision-making, structure and network, without taking over operational management.
Sundae Foods develops solutions at the intersection of nutrition, technology and convenience. 3M Invest is involved as a growth investor.
View Sundae FoodsHealthcareNLKG is a nationwide group of specialised medical clinics. 3M Invest participates in NLKG through partner MG Partners.
View NLKG3M Invest invests €50,000 to €2,000,000 per opportunity, combining governance, network and active involvement. An orienting conversation is the first step.